Einzeltreffer — DigiBib

Background: Studies assessing the indirect impact of COVID-19 using mathematical models have increased in recent years. This scoping review aims to identify modelling studies assessing the potential impact of disruptions to essential health services caused by COVID-19 and to summarise the characteristics of disruption and the models used to assess the disruptions.

Methods: Eligible studies were included if they used any models to assess the impact of COVID-19 disruptions on any health services. Articles published from January 2020 to December 2022 were identified from PubMed, Embase and CINAHL, using detailed searches with key concepts including COVID-19, modelling and healthcare disruptions. Two reviewers independently extracted the data in four domains. A descriptive analysis of the included studies was performed under the format of a narrative report.

Results: This scoping review has identified a total of 52 modelling studies that employed several models (n=116) to assess the potential impact of disruptions to essential health services. The majority of the models were simulation models (n=86; 74.1%). Studies covered a wide range of health conditions from infectious diseases to non-communicable diseases. COVID-19 has been reported to disrupt supply of health services, demand for health services and social change affecting factors that influence health. The most common outcomes reported in the studies were clinical outcomes such as mortality and morbidity. Twenty-five studies modelled various mitigation strategies; maintaining critical services by ensuring resources and access to services are found to be a priority for reducing the overall impact.

Conclusion: A number of models were used to assess the potential impact of disruptions to essential health services on various outcomes. There is a need for collaboration among stakeholders to enhance the usefulness of any modelling. Future studies should consider disparity issues for more comprehensive findings that could ultimately facilitate policy decision-making to maximise benefits to all.

Competing Interests: Competing interests: None declared.

Titel:	Scoping review of modelling studies assessing the impact of disruptions to essential health services during COVID-19.
Autor/in / Beteiligte Person:	Veettil, SK ; Schwerer, L ; Kategeaw, W ; Toth, D ; Samore, MH ; Hutubessy, R ; Chaiyakunapruk, N
Zeitschrift:	BMJ open, Jg. 13 (2023-09-26), Heft 9, S. e071799
Veröffentlichung:	[London] : BMJ Publishing Group Ltd, 2011-, 2023
Medientyp:	academicJournal
ISSN:	2044-6055 (electronic)
DOI:	10.1136/bmjopen-2023-071799
Schlagwort:	Humans Health Services Delivery of Health Care Models, Theoretical Policy Making COVID-19 epidemiology
Sonstiges:	Nachgewiesen in: MEDLINE Sprachen: English Publication Type: Review; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. Language: English [BMJ Open] 2023 Sep 26; Vol. 13 (9), pp. e071799. <i>Date of Electronic Publication: </i>2023 Sep 26. MeSH Terms: COVID-19* / epidemiology ; Humans ; Health Services ; Delivery of Health Care ; Models, Theoretical ; Policy Making References: J Med Screen. 2021 Jun;28(2):213-216. (PMID: 33730899) ; Semin Vasc Surg. 2021 Sep;34(3):82-88. (PMID: 34642040) ; Arch Argent Pediatr. 2021 Aug;119(4):266-269. (PMID: 34309303) ; Sex Transm Dis. 2022 Feb 1;49(2):145-153. (PMID: 34475357) ; Biomedica. 2021 Oct 15;41(Sp. 2):118-129. (PMID: 34669283) ; PLoS One. 2022 Jul 18;17(7):e0271523. (PMID: 35849613) ; Pharmacoeconomics. 2008;26(3):191-215. (PMID: 18282015) ; Lancet Glob Health. 2022 Nov;10(11):e1600-e1611. (PMID: 36240827) ; Vaccine. 2022 Jul 29;40(31):4142-4149. (PMID: 35672179) ; Eur Respir J. 2020 Aug 13;56(2):. (PMID: 32513784) ; PLoS One. 2021 Jun 15;16(6):e0253327. (PMID: 34129649) ; Prev Med. 2021 Oct;151:106623. (PMID: 34029578) ; Pathog Glob Health. 2021 Mar;115(2):93-99. (PMID: 33320773) ; J Med Screen. 2021 Jun;28(2):100-107. (PMID: 33241760) ; PLoS One. 2021 Dec 23;16(12):e0260820. (PMID: 34941876) ; J Int AIDS Soc. 2021 Apr;24(4):e25697. (PMID: 33821553) ; PLoS One. 2021 May 27;16(5):e0246053. (PMID: 34043626) ; Trans R Soc Trop Med Hyg. 2021 Mar 6;115(3):269-280. (PMID: 33515042) ; Trans R Soc Trop Med Hyg. 2021 Mar 6;115(3):236-244. (PMID: 33515038) ; Trans R Soc Trop Med Hyg. 2021 Mar 6;115(3):261-268. (PMID: 33515454) ; J Natl Cancer Inst. 2021 Nov 2;113(11):1484-1494. (PMID: 34258611) ; J Acquir Immune Defic Syndr. 2021 Jul 1;87(3):899-911. (PMID: 33657058) ; J Med Screen. 2022 Jun;29(2):72-83. (PMID: 35100894) ; EClinicalMedicine. 2020 Jul 31;26:100483. (PMID: 33089116) ; Med Care. 2021 Mar 1;59(3):213-219. (PMID: 33427797) ; Lancet Reg Health West Pac. 2021 Nov;16:100262. (PMID: 34514452) ; Prev Med. 2022 Jul;160:107076. (PMID: 35526674) ; Sci Rep. 2022 Aug 12;12(1):13773. (PMID: 35962020) ; J Int AIDS Soc. 2022 Jan;25(1):e25864. (PMID: 35048515) ; Lancet HIV. 2021 Apr;8(4):e206-e215. (PMID: 33617783) ; EClinicalMedicine. 2020 Oct 24;28:100603. (PMID: 33134905) ; Soc Sci Med. 2022 Aug;307:115164. (PMID: 35816834) ; PLoS One. 2021 Aug 9;16(8):e0239352. (PMID: 34370739) ; Trans R Soc Trop Med Hyg. 2021 Mar 6;115(3):222-228. (PMID: 33449114) ; Trans R Soc Trop Med Hyg. 2021 Mar 6;115(3):253-260. (PMID: 33313897) ; Int J Cancer. 2022 Apr 15;150(8):1244-1254. (PMID: 34843106) ; Prev Med. 2023 Jan;166:107376. (PMID: 36493865) ; BMC Ophthalmol. 2021 May 10;21(1):206. (PMID: 33971832) ; Lancet Glob Health. 2020 Sep;8(9):e1132-e1141. (PMID: 32673577) ; Elife. 2021 Jun 24;10:. (PMID: 34165077) ; Eur J Cancer. 2021 Aug;153:123-132. (PMID: 34153714) ; Ann Intern Med. 2018 Oct 2;169(7):467-473. (PMID: 30178033) ; Lancet Oncol. 2021 Oct;22(10):1427-1437. (PMID: 34487693) ; Clin Infect Dis. 2022 Aug 24;75(1):e1112-e1119. (PMID: 34499124) ; Vaccines (Basel). 2021 Oct 22;9(11):. (PMID: 34835161) ; J Cyst Fibros. 2021 Dec;20 Suppl 3:16-20. (PMID: 34930535) ; Lancet Gastroenterol Hepatol. 2021 Apr;6(4):304-314. (PMID: 33548185) ; Trans R Soc Trop Med Hyg. 2021 Mar 6;115(3):213-221. (PMID: 33596317) ; Can J Kidney Health Dis. 2021 Sep 14;8:20543581211040332. (PMID: 34540237) ; Lancet Glob Health. 2020 Jul;8(7):e901-e908. (PMID: 32405459) ; Science. 2020 Jul 24;369(6502):413-422. (PMID: 32532802) ; Nat Med. 2020 Sep;26(9):1411-1416. (PMID: 32770167) ; Epidemics. 2022 Mar;38:100552. (PMID: 35259693) ; J Infect Dis. 2021 Mar 29;223(6):1019-1028. (PMID: 33507308) ; Lancet Infect Dis. 2021 Jan;21(1):59-69. (PMID: 32971006) ; Comput Biol Med. 2021 Jun;133:104429. (PMID: 33930765) ; Clin Infect Dis. 2022 Aug 24;75(1):e1145-e1153. (PMID: 35016216) ; Lancet HIV. 2020 Sep;7(9):e629-e640. (PMID: 32771089) ; Health Res Policy Syst. 2018 Jul 11;16(1):60. (PMID: 29996848) ; J Hepatol. 2021 Jan;74(1):31-36. (PMID: 32777322) Grant Information: 001 International WHO_ World Health Organization Contributed Indexing: Keywords: Covid-19; public health; scoping review Entry Date(s): Date Created: 20230926 Date Completed: 20231002 Latest Revision: 20231214 Update Code: 20231215 PubMed Central ID: PMC10533712

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

Scoping review of modelling studies assessing the impact of disruptions to essential health services during COVID-19.